Clinical Study

Uccc Bn-20-01 The Use Of Active Vs Receptive Music Listening To Reduce Symptoms Of Chemobrain In Breast Cancer Survivors

Posted Date: Aug 3, 2021

  • Investigator: Yehudit Rothman
  • Specialties: Breast Cancer, Cancer, Oncology
  • Type of Study: Observational/Survey

The objective of this study will be to reduce executive function deficits and improve quality of life in breast cancer survivors who have previously had adjuvant chemotherapy and to test the preliminary outcomes of music listening interventions in breast cancer survivors. There will be 2 groups: Group A and Group B. Group A will engage in active listening using a voice command app, while Group B will engage in receptive listening to instrumentals from their selected genre.


Patients Must Have Had A Breast Cancer Diagnosis. Patients Must Have Previously Completed Adjuvant Chemotherapy. Patients Must Be Older Than 21 Years Old. Must Have A Score Of At Least 22 On The Montreal Cognitive Assessment. Must Have The Ability To Access A Reliable Internet Connection Daily To Support Use Of The App On An Ipad. No Patients 20 Years Or Younger. No Patients Who Are Currently Receiving Any Chemotherapy Regimen. No Patients Who Have Known Active Mental Illness. No Patients With Current Malignant Cancers. No Patients With Known Allergy To Mri Contrast. No Complete Bilateral Hearing Loss. No Known Underlying Neurodegenerative Disease.


Breast Cancer

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.